JP2010509345A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509345A5 JP2010509345A5 JP2009536348A JP2009536348A JP2010509345A5 JP 2010509345 A5 JP2010509345 A5 JP 2010509345A5 JP 2009536348 A JP2009536348 A JP 2009536348A JP 2009536348 A JP2009536348 A JP 2009536348A JP 2010509345 A5 JP2010509345 A5 JP 2010509345A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- polypeptide
- seq
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85802206P | 2006-11-10 | 2006-11-10 | |
| US60/858,022 | 2006-11-10 | ||
| PCT/US2007/023951 WO2008057609A2 (en) | 2006-11-10 | 2007-11-13 | Methods of treating neuronal disorders using mntf peptides and analogs thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010509345A JP2010509345A (ja) | 2010-03-25 |
| JP2010509345A5 true JP2010509345A5 (cg-RX-API-DMAC10.html) | 2010-11-11 |
| JP5336384B2 JP5336384B2 (ja) | 2013-11-06 |
Family
ID=39365151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009536348A Expired - Fee Related JP5336384B2 (ja) | 2006-11-10 | 2007-11-13 | Ｍｎｔｆペプチドおよびその類似体を用いて神経細胞障害を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8673852B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2086331B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5336384B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN101534648B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2007317730B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2669658C (cg-RX-API-DMAC10.html) |
| DK (1) | DK2086331T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2407454T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008057609A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8846615B2 (en) * | 2008-02-21 | 2014-09-30 | Genervon Biopharmaceuticals, LLC | MNTF peptides |
| RU2012123642A (ru) * | 2009-12-11 | 2014-01-20 | Кейз Вестерн Ризев Юнивесити | Аналоги инсулина, содержащие хлорированные аминокислоты |
| GB201015569D0 (en) * | 2010-09-16 | 2010-10-27 | Medical Res Council | Blood assay for prions |
| WO2016210123A1 (en) | 2015-06-26 | 2016-12-29 | Genervon Biopharmaceuticals, LLC | Methods of using gm604 in modulating als disease biomarkers leading to prognosis and therapeutic treatment for als disease |
| WO2018119018A1 (en) * | 2016-12-23 | 2018-06-28 | Genervon Biopharmaceuticals, LLC | Methods of using gm6 in diagnosing and treating alzheimer's disease |
| WO2018129421A1 (en) * | 2017-01-09 | 2018-07-12 | Genervon Biopharmaceuticals, LLC | A promising drug candidate for parkinson's disease |
| AU2019277920A1 (en) * | 2018-05-31 | 2021-01-07 | Immunity Pharma Ltd. | Compositions and methods of using same for treating amyotrophic lateral sclerosis (ALS) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309877B1 (en) * | 1996-09-27 | 2001-10-30 | Km Biotech, Inc. | Polynucleotides encoding motoneuronotrophic factors |
| US6841531B2 (en) * | 1996-09-27 | 2005-01-11 | Genervon Biopharmaceuticals Llc | Methods and use of motoneuronotrophic factors |
| WO2004065410A2 (en) * | 2003-01-21 | 2004-08-05 | Genervon Biopharmaceuticals Llc | Mntf peptides and compositions and methods of use |
-
2007
- 2007-11-13 US US11/939,384 patent/US8673852B2/en active Active
- 2007-11-13 JP JP2009536348A patent/JP5336384B2/ja not_active Expired - Fee Related
- 2007-11-13 CA CA2669658A patent/CA2669658C/en not_active Expired - Fee Related
- 2007-11-13 WO PCT/US2007/023951 patent/WO2008057609A2/en not_active Ceased
- 2007-11-13 CN CN2007800419244A patent/CN101534648B/zh not_active Expired - Fee Related
- 2007-11-13 AU AU2007317730A patent/AU2007317730B2/en not_active Ceased
- 2007-11-13 EP EP07867451A patent/EP2086331B1/en not_active Not-in-force
- 2007-11-13 ES ES07867451T patent/ES2407454T3/es active Active
- 2007-11-13 DK DK07867451.2T patent/DK2086331T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012525844A5 (cg-RX-API-DMAC10.html) | ||
| WO2008057609A4 (en) | Methods of treating neuronal disorders using mntf peptides and analogs thereof | |
| US20140213512A1 (en) | Method of Treating or Ameliorating Type 1 Diabetes Using FGF21 | |
| JP2010513506A5 (cg-RX-API-DMAC10.html) | ||
| JP2017502920A5 (cg-RX-API-DMAC10.html) | ||
| JP2010534486A5 (cg-RX-API-DMAC10.html) | ||
| JP2009545313A5 (cg-RX-API-DMAC10.html) | ||
| JP2007518818A5 (cg-RX-API-DMAC10.html) | ||
| JP2010505444A5 (cg-RX-API-DMAC10.html) | ||
| JP2011526886A5 (cg-RX-API-DMAC10.html) | ||
| JP2020509011A (ja) | エリスロポエチン由来ペプチドの細胞損傷防止に対する効果を介した活用 | |
| RU2010111114A (ru) | Нейропротективное действие с применением nap-подобных и sal-подобных пептидных миметиков | |
| MX2025002887A (es) | Polipéptidos de fc modificados con sialilación mejorada | |
| JP6529606B2 (ja) | 自己免疫障害及び炎症障害を治療及び／又は予防するための短い合成ペプチド | |
| JP2006506942A5 (cg-RX-API-DMAC10.html) | ||
| JP2019535267A5 (cg-RX-API-DMAC10.html) | ||
| JP2014520764A5 (cg-RX-API-DMAC10.html) | ||
| AU2006310577B2 (en) | Use of SDF-1 for the treatment and/or prevention of neurological diseases | |
| JP2009513689A5 (cg-RX-API-DMAC10.html) | ||
| RU2009103811A (ru) | Аналоги вазоактивного интестинального пептида | |
| WO2003018754A3 (en) | Neural regeneration peptide and methods for their use in treatment of brain damage | |
| JP2019501112A5 (cg-RX-API-DMAC10.html) | ||
| CA2581110A1 (en) | Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions | |
| RU2014117975A (ru) | Гибридные белки и белковые конъюгаты на основе белков теплового шока-70 (бтш70) и способы их применения (варианты) | |
| JP2015514771A5 (cg-RX-API-DMAC10.html) |